Medicaid ‘Unwinding:’ Much Of The Reduction In Medicaid-Paid Prescriptions Was Offset By Increased Commercial Coverage

With the expiration of the Medicaid continuous coverage condition on March 31, 2023, states began returning to regular eligibility renewals in Medicaid and the Children's Health Insurance Program (CHIP). Because of incompleteness of administrative data and lags in the availability of survey data, there is limited understanding of how this "unwinding" process has affected insurance coverage or access to care. Using data from IQVIA PayerTrak, a large, nationally representative, all-payer pharmacy transactions database, we examined the trends in prescription drug use during the unwinding period. Leveraging state variation in Medicaid coverage termination start dates, we found that although prescriptions paid for by Medicaid or CHIP fell during unwinding, this decline was mostly offset by an increase in commercial-paid prescriptions. Total prescriptions were unchanged, suggesting that the unwinding did not result in reduced access to medications.

Authors

Institutions

Publication Details

Journal
Health Affairs
Published
2025-05-01
DOI
https://doi.org/10.1377/hlthaff.2024.01492
Citations
2
Primary Topic
Healthcare Policy and Management
Type
article
Field-Weighted Citation Impact
6.26
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Medicaid ‘Unwinding:’ Much Of The Reduction In Medicaid-Paid Prescriptions Was Offset By Increased Commercial Coverage

Kenneth Finegold, Thomas C. Buchmueller, Arielle Bosworth, Е. М. Волков et al.
2 citations
Health Affairs
Healthcare Policy and Management
6.26
article

Medicaid ‘Unwinding:’ Much Of The Reduction In Medicaid-Paid Prescriptions Was Offset By Increased Commercial Coverage

Kenneth Finegold, Thomas C. Buchmueller, Arielle Bosworth, Е. М. Волков, Jessica Eloso
article en
2 citations

Abstract

With the expiration of the Medicaid continuous coverage condition on March 31, 2023, states began returning to regular eligibility renewals in Medicaid and the Children's Health Insurance Program (CHIP). Because of incompleteness of administrative data and lags in the availability of survey data, there is limited understanding of how this "unwinding" process has affected insurance coverage or access to care. Using data from IQVIA PayerTrak, a large, nationally representative, all-payer pharmacy transactions database, we examined the trends in prescription drug use during the unwinding period. Leveraging state variation in Medicaid coverage termination start dates, we found that although prescriptions paid for by Medicaid or CHIP fell during unwinding, this decline was mostly offset by an increase in commercial-paid prescriptions. Total prescriptions were unchanged, suggesting that the unwinding did not result in reduced access to medications.

Health AffairsVol. 44(5)
Brookings Institution (US), Princeton University (US), Pskov Volny Institute (RU), Jesus University (KR), American University for Humanities (US)
Openalex Percentile: Top 4%
Healthcare Policy and Management
6.26
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.